Di Girolamo M, Silletta M G, De Matteis M A, Braca A, Colanzi A, Pawlak D, Rasenick M M, Luini A, Corda D
Laboratory of Cellular and Molecular Endocrinology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy.
Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7065-9. doi: 10.1073/pnas.92.15.7065.
Brefeldin A, a fungal metabolite that inhibits membrane transport, induces the mono(ADP-ribosyl)ation of two cytosolic proteins of 38 and 50 kDa as judged by SDS/PAGE. The 38-kDa substrate has been previously identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH). We report that the 50-kDa BFA-induced ADP-ribosylated substrate (BARS-50) has native forms of 170 and 130 kDa, as determined by gel filtration of rat brain cytosol, indicating that BARS-50 might exist as a multimeric complex. BARS-50 can bind GTP, as indicated by blot-overlay studies with [alpha-32P]GTP and by photoaffinity labeling with guanosine 5'-[gamma-32P] [beta,gamma-(4-azidoanilido)]triphosphate. Moreover, ADP-ribosylation of BARS-50 was completely inhibited by the beta gamma subunit complex of G proteins, while the ADP-ribosylation of GAPDH was unmodified, indicating that this effect was due to an interaction of the beta gamma complex with BARS-50, rather than with the ADP-ribosylating enzyme. Two-dimensional gel electrophoresis and immunoblot analysis shows that BARS-50 is a group of closely related proteins that appear to be different from all the known GTP-binding proteins.
布雷菲德菌素A是一种抑制膜转运的真菌代谢产物,通过SDS/PAGE判断,它能诱导38 kDa和50 kDa两种胞质蛋白发生单(ADP - 核糖基)化。38 kDa的底物先前已被鉴定为甘油醛 - 3 - 磷酸脱氢酶(GAPDH)。我们报告称,通过对大鼠脑细胞质溶胶进行凝胶过滤测定,50 kDa的布雷菲德菌素A诱导的ADP - 核糖基化底物(BARS - 50)有170 kDa和130 kDa的天然形式,这表明BARS - 50可能以多聚体复合物的形式存在。如用[α - 32P]GTP进行印迹覆盖研究以及用鸟苷5'-[γ - 32P][β,γ - (4 - 叠氮苯胺基)]三磷酸进行光亲和标记所示,BARS - 50能结合GTP。此外,G蛋白的βγ亚基复合物完全抑制了BARS - 50的ADP - 核糖基化,而GAPDH的ADP - 核糖基化未受影响,这表明这种效应是由于βγ复合物与BARS - 50相互作用,而非与ADP - 核糖基化酶相互作用所致。二维凝胶电泳和免疫印迹分析表明,BARS - 50是一组密切相关的蛋白质,似乎与所有已知的GTP结合蛋白都不同。